Amphastar Pharmaceuticals, Inc. (AMPH) vs Pacira BioSciences, Inc. (PCRX)
- Amphastar Pharmaceuticals, Inc. AMPH 25.87 −2.08%
- Pacira BioSciences, Inc. PCRX 36.35 +0.06%
Amphastar Pharmaceuticals, Inc. and Pacira BioSciences, Inc. are both Drug Manufacturers Specialty & Generic companies. Pacira BioSciences, Inc. is the larger, with a market value of $1.5B against $1.1B — 1.3× the size. Amphastar Pharmaceuticals, Inc. trades at the lower P/E: 14.9× against 104×. Pacira BioSciences, Inc. grew revenue faster over the last twelve months: 5.71% against 1.02%. Amphastar Pharmaceuticals, Inc. has the higher net margin (10.8% vs 1.96%) and the higher return on invested capital (6.57% vs 1.58%). Across the 22 metrics below, Amphastar Pharmaceuticals, Inc. leads on 15 and Pacira BioSciences, Inc. on 7.
Valuation
Profitability
| Metric | AMPH | PCRX | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 47.68% | 79.21% | 53.94% |
| Operating margin | 15.66% | 2.66% | 0.00% |
| Net margin | 10.76% | 1.96% | 0.00% |
| Free cash flow margin | 20.94% | 24.06% | 0.00% |
| Return on equity | 10.30% | 2.05% | (0.40%) |
| Return on assets | 4.68% | 1.05% | (3.32%) |
| Return on invested capital | 6.57% | 1.58% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack